TransCode Therapeutics, Inc. (NASDAQ:RNAZ) IPO

TransCode Therapeutics, Inc.

IPO

Priced at US$4.00 a share on Jul 8, 2021.

Price
US$4.00 a share
Shares offered
6,250,000 shares of common stock
Offering size
US$25 million
Underwriters' option
Up to 937,500 more shares
Listing
RNAZ on the Nasdaq Capital Market
Underwriter
ThinkEquity
Shares delivered
On or about Jul 13, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceDec 18, 2020
Filed publiclyFeb 26, 2021
Amended 5 timesNewest Jun 2, 2021
Shares registered with an exchangeApr 26, 2021
Declared effective by the SECJul 8, 2021
Final prospectus, with the priceJul 9, 2021

From the cover of the final prospectus (424B4) filed Jul 9, 2021